OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 22,500 Shares

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 22,500 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $23.35, for a total value of $525,375.00. Following the completion of the sale, the insider directly owned 6,504,133 shares of the company’s stock, valued at approximately $151,871,505.55. This represents a 0.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

OrthoPediatrics Price Performance

NASDAQ KIDS traded down $0.18 on Friday, reaching $22.41. 129,506 shares of the company’s stock traded hands, compared to its average volume of 173,525. The stock has a market cap of $585.13 million, a PE ratio of -13.34 and a beta of 0.99. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74. The stock has a 50-day simple moving average of $21.74 and a 200 day simple moving average of $18.84. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The firm had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. As a group, research analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

KIDS has been the topic of several analyst reports. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. Needham & Company LLC raised their price target on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. BTIG Research boosted their price objective on OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, August 20th. Finally, Piper Sandler reissued an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Nine equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $26.44.

Hedge Funds Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently made changes to their positions in the business. Millennium Management LLC lifted its position in shares of OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock worth $24,802,000 after purchasing an additional 452,840 shares during the period. BlackRock Inc. bought a new stake in OrthoPediatrics during the 2nd quarter valued at approximately $24,347,000. Vanguard Group Inc. raised its position in shares of OrthoPediatrics by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock worth $17,813,000 after acquiring an additional 10,927 shares in the last quarter. Granahan Investment Management LLC lifted its stake in shares of OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock valued at $14,231,000 after purchasing an additional 232,760 shares during the period. Finally, Wasatch Advisors LP boosted its position in shares of OrthoPediatrics by 56.6% during the second quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock valued at $9,865,000 after purchasing an additional 186,357 shares in the last quarter. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.